Global malaria control funding has gone up significantly since 2007, but funding shortfall remains, study says

NewsGuard 100/100 Score

Global malaria funding has gone up by 166 percent since 2007, but total funding is still 60 percent short of the $4.9 billion required for comprehensive malaria control this year, according to a study published in the journal Lancet on Saturday, Agence France-Presse reports. Malaria control financing has risen from $730 million in 2007 to $1.94 billion this year, according to the analysis (10/2).

The study found "that 21 countries - including 12 in Africa - now get enough or nearly enough donor help to control disease," Reuters writes of the research, which "assessed the level of malaria risk for 93 countries where the disease is endemic and calculated the financial requirements to control it." But the researchers found that funding in 50 countries, where the majority of people at risk for contracting malaria live, was not adequate (10/2). The research also showed that "China and India, as well as two African countries, Equatorial Guinea and Gabon, have economies that are strong enough to support malaria programmes" with just domestic resources, AFP writes (10/2).

The requirement of $4.9 billion for malaria funding is based on a Roll Back Malaria estimate, the BBC reports. Professor Bob Snow of Oxford University led the Lancet study and collaborated with researchers from Kenya's Kenyatta National Hospital.

"Poor countries with inadequate donor assistance and large sectors of their population at risk of malaria must remain the focus of attention if global ambitions for malaria control are to be realised," Snow said. "The challenge will now be on finding more money, making sure funding is linked to performance and putting pressure on malaria-endemic countries with large domestic incomes to do more for themselves. A failure to maintain the momentum will mean money spent so far will have been for nothing."

The BBC also reports on a related Lancet Comment, where Professor Anne Mills, from the London School of Hygiene and Tropical Medicine, pointed out that in some cases, external funding might be low because a country is funding its own malaria control efforts (Lichtarowicz, 10/1).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show